Since its inception in 2000, Ontario Genomics has supported the commercialization of genomics technologies and products through early-stage funding, co-funding, or creation of these companies:
- Northern Biologics
- ProMIS Neurosciences (Amorfix)
- RNA Diagnostics
- Savant
- Tissue Regeneration Therapeutics Inc
- Vasomune
- Xagenic Canada Inc.
The following companies were supported by Genome Canada’s Genomics Application Partnership Program (GAPP) in partnership between academic researchers and industry, to promote the application of genomics-derived solutions to address key sector challenges.
- Xagenic Canada Inc.
- Vineland Research and Innovation Centre
- Cooke Aquaculture Inc. and Kelly Cove Salmon Ltd.
- Assurex Health
- Vasomune Therapeutics
- Roche Diagnostics International Ltd.
- LifeLabs Medical Laboratory Services
- United Therapeutics (Lung Bioengineering Inc.)